Want to see IN:ACI full AI Analyst Report?
Top Page
Archean Chemical Industries Ltd.
(ACI)
Select Model
Select Model
Rating:52Neutral
Price Target:
₹603.00
▲(7.26% Upside)
Action:Reiterated
Date:05/13/26
The score is held back primarily by deteriorating fundamentals—especially weak cash conversion and negative free cash flow—along with a relatively expensive valuation (high P/E, low yield). Technical indicators are mixed and only mildly supportive, and the balance sheet remains generally healthy but with rising leverage.
Positive Factors
Specialty product mix & export orientation
Archean’s focus on industrial salt and bromine-derived specialty chemicals and meaningful exports supports durable demand diversity. Specialty and export exposure underpin pricing power with industrial customers and higher value add versus commoditized chemicals, aiding long-term revenue resilience.
Negative Factors
Weak cash generation and negative FCF
Sharp deterioration in cash conversion and recurring negative free cash flow reduce financial flexibility. Sustained negative FCF can force higher borrowing or defer maintenance and growth capex, weakening the firm’s ability to fund operations and strategic initiatives without raising costlier capital.
Read all positive and negative factors
Positive Factors
Negative Factors
Specialty product mix & export orientation
Archean’s focus on industrial salt and bromine-derived specialty chemicals and meaningful exports supports durable demand diversity. Specialty and export exposure underpin pricing power with industrial customers and higher value add versus commoditized chemicals, aiding long-term revenue resilience.
Read all positive factors
Archean Chemical Industries Ltd. (ACI) vs. iShares MSCI India ETF (INDA)
Market Cap
₹67.90B
Dividend Yield0.78%
Average Volume (3M)8.93K
Price to Earnings (P/E)63.6
Beta (1Y)0.64
Revenue Growth3.85%
EPS Growth-34.43%
CountryIN
Employees257
SectorGeneral
Sector StrengthN/A
IndustryChemicals
Share Statistics
EPS (TTM)8.65
Shares Outstanding123,458,400
10 Day Avg. Volume6,499
30 Day Avg. Volume8,929
Financial Highlights & Ratios
PEG Ratio-1.99
Price to Book (P/B)3.75
Price to Sales (P/S)6.71
P/FCF Ratio-29.01
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)21.96
Revenue Forecast (FY)₹15.17B
Archean Chemical Industries Ltd. Business Overview & Revenue Model
Company Description
Archean Chemical Industries Limited operates as a manufacturer and global distributor of specialized chemicals extracted from marine sources, serving markets both within India and worldwide. Its product portfolio prominently features bromine, an e...
How the Company Makes Money
ACI primarily makes money by manufacturing and selling specialty marine chemicals, with revenue driven mainly by (1) industrial salt sales and (2) bromine and bromine-derivative product sales to industrial customers. The company generates sales th...
Archean Chemical Industries Ltd. Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
70
Positive
Cash Flow
38
Negative
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 10.81B | 10.41B | 13.30B | 14.40B | 11.30B |
| Gross Profit | 7.20B | 10.49B | 12.16B | 14.37B | 8.50B |
| EBITDA | 2.47B | 3.11B | 5.06B | 6.77B | 4.79B |
| Net Income | 1.07B | 1.62B | 3.19B | 3.83B | 1.88B |
Balance Sheet | |||||
| Total Assets | 26.65B | 23.93B | 20.56B | 17.55B | 15.31B |
| Cash, Cash Equivalents and Short-Term Investments | 610.77M | 2.55B | 3.95B | 2.31B | 695.11M |
| Total Debt | 4.66B | 2.35B | 978.23M | 693.85M | 9.00B |
| Total Liabilities | 7.32B | 5.29B | 3.54B | 3.24B | 12.69B |
| Stockholders Equity | 19.34B | 18.64B | 17.02B | 14.31B | 2.62B |
Cash Flow | |||||
| Free Cash Flow | -2.50B | -873.38M | 1.71B | 3.96B | 2.18B |
| Operating Cash Flow | 1.32B | 1.76B | 3.79B | 4.96B | 3.15B |
| Investing Cash Flow | -2.96B | -2.46B | -3.07B | -2.90B | -1.10B |
| Financing Cash Flow | 1.64B | 649.80M | -325.69M | -2.12B | -2.24B |
Archean Chemical Industries Ltd. Technical Analysis
Positive
562.20
Price Trends
538.05
Positive
560.75
Negative
569.89
Negative
Market Momentum
1.36
Negative
60.01
Neutral
61.61
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ACI, the sentiment is Positive. The current price of 562.2 is above the 20-day moving average (MA) of 530.83, above the 50-day MA of 538.05, and below the 200-day MA of 569.89, indicating a neutral trend. The MACD of 1.36 indicates Negative momentum. The RSI at 60.01 is Neutral, neither overbought nor oversold. The STOCH value of 61.61 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:ACI.
Archean Chemical Industries Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ₹73.88B | 9.14 | ― | 3.68% | -1.51% | 35.32% | |
75 Outperform | ₹40.03B | 8.72 | ― | 2.10% | -3.75% | -23.38% | |
57 Neutral | ₹43.11B | -1,776.36 | ― | 3.11% | 7.00% | 96.30% | |
56 Neutral | ₹233.08B | 42.32 | ― | 0.44% | -4.13% | -21.05% | |
56 Neutral | ₹177.87B | -9.39 | ― | 1.42% | -2.04% | -906.81% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
52 Neutral | ₹67.90B | 63.63 | ― | 0.78% | 3.85% | -34.43% |
* General Sector Average
IN:ACI
Archean Chemical Industries Ltd.
550.00
-147.51
-21.15%
IN:DEEPAKNTR
Deepak Nitrite Limited
1,708.85
-219.52
-11.38%
IN:GHCL
Ghcl Limited
434.45
-153.94
-26.16%
IN:GNFC
Gujarat Narmada Valley Fertilizers & Chemicals Ltd.
502.80
-25.60
-4.84%
IN:GUJALKALI
Gujarat Alkalies & Chemicals Ltd.
587.05
13.62
2.38%
IN:TATACHEM
Tata Chemicals Limited
698.20
-227.67
-24.59%
Archean Chemical Industries Ltd. Corporate Events
Archean Chemical releases FY26 earnings call investor presentation
May 12, 2026
Archean Chemical Industries Ltd. has released an investor presentation tied to its earnings call for the quarter and full year ended March 31, 2026. The materials have been filed with Indian stock exchanges and made available on the company’...
Archean Chemical Unveils FY26 Results, Dividend and Board Reappointments
May 11, 2026
Archean Chemical Industries reported its audited standalone and consolidated financial results for the quarter and full year ended 31 March 2026, with audit opinions remaining unmodified, signaling clean assurance on its accounts. The company plan...
Archean Chemical Reappoints Statutory Auditors and Independent Directors to Strengthen Governance
May 11, 2026
Archean Chemical Industries Ltd. has approved the re-appointment of PKF Sridhar Santhanam LLP as its statutory auditors for a second four-year term, starting from the conclusion of its 17th Annual General Meeting in June 2026 and running through ...
Archean Chemical Reappoints Statutory Auditors and Independent Directors to Bolster Governance Stability
May 11, 2026
Archean Chemical Industries Ltd. has reappointed PKF Sridhar Santhanam LLP as its statutory auditors for a second four-year term, starting after the upcoming 17th Annual General Meeting in June 2026 and extending through the 21st AGM in 2030, sub...
Archean Chemical Recommends Final Dividend, Sets Key Dates for FY 2025-26
May 11, 2026
Archean Chemical Industries Ltd.’s board has recommended a final dividend of Rs 2.50 per equity share of Rs 2 each for the financial year ended March 31, 2026, to be paid within 30 days of shareholder approval at the upcoming annual general ...
Archean Chemical Clarifies Non-Large Corporate Status Under SEBI Norms
May 11, 2026
Archean Chemical Industries Ltd. has clarified that it does not qualify as a Large Corporate under recent SEBI guidelines, based on its current borrowing profile and regulatory criteria. As of March 31, 2026, the company reported long-term bank lo...
Archean Chemical Secures SEBI Compliance Certificate for Demat Processes
Apr 15, 2026
Archean Chemical Industries Ltd. has notified the stock exchanges that it has received a compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The registra...
Archean Chemical to Merge Two Idealis Subsidiaries in Group Reorganisation
Mar 19, 2026
Archean Chemical Industries Ltd. has approved the merger of its wholly owned subsidiary Idealis Chemicals Pvt. Ltd. with Idealis Mudchemie Pvt. Ltd., a wholly owned subsidiary of Idealis and step-down subsidiary of Archean. Both entities, headquar...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.